The importance of the number of antihypertensives in the progression of autosomal dominant polycystic kidney disease

Nefrologia (Engl Ed). 2021 May-Jun;41(3):362-364. doi: 10.1016/j.nefroe.2021.07.002. Epub 2021 Jul 27.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antihypertensive Agents / therapeutic use
  • Humans
  • Hypertension* / drug therapy
  • Kidney
  • Polycystic Kidney, Autosomal Dominant* / complications
  • Polycystic Kidney, Autosomal Dominant* / drug therapy

Substances

  • Antihypertensive Agents